ID GSTA3_HUMAN Reviewed; 222 AA. AC Q16772; O43468; Q068V6; Q8WWA8; Q9H415; DT 15-JUL-1999, integrated into UniProtKB/Swiss-Prot. DT 27-MAY-2002, sequence version 3. DT 24-JAN-2024, entry version 197. DE RecName: Full=Glutathione S-transferase A3 {ECO:0000305}; DE EC=2.5.1.18; DE AltName: Full=GST class-alpha member 3; DE AltName: Full=Glutathione S-transferase A3-3; GN Name=GSTA3 {ECO:0000312|HGNC:HGNC:4628}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA]. RX PubMed=8307579; DOI=10.1016/s0888-7543(05)80373-8; RA Suzuki T., Johnston P.N., Board P.G.; RT "Structure and organization of the human alpha class glutathione S- RT transferase genes and related pseudogenes."; RL Genomics 18:680-686(1993). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA], CHARACTERIZATION, CATALYTIC ACTIVITY, FUNCTION, RP AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=11418619; DOI=10.1074/jbc.m104539200; RA Johansson A.-S., Mannervik B.; RT "Human glutathione transferase A3-3, a highly efficient catalyst of double- RT bond isomerization in the biosynthetic pathway of steroid hormones."; RL J. Biol. Chem. 276:33061-33065(2001). RN [3] RP NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS GLU-36; LEU-71; ASP-73; RP GLN-113 AND THR-208. RG NIEHS SNPs program; RL Submitted (SEP-2006) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=14574404; DOI=10.1038/nature02055; RA Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., RA Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., RA Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., RA Andrews T.D., Ashwell R.I.S., Babbage A.K., Bagguley C.L., Bailey J., RA Banerjee R., Barker D.J., Barlow K.F., Bates K., Beare D.M., Beasley H., RA Beasley O., Bird C.P., Blakey S.E., Bray-Allen S., Brook J., Brown A.J., RA Brown J.Y., Burford D.C., Burrill W., Burton J., Carder C., Carter N.P., RA Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V., RA Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J., RA Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E., Ellington A.E., RA Evans K.A., Faulkner L., Francis M.D., Frankish A., Frankland J., RA French L., Garner P., Garnett J., Ghori M.J., Gilby L.M., Gillson C.J., RA Glithero R.J., Grafham D.V., Grant M., Gribble S., Griffiths C., RA Griffiths M.N.D., Hall R., Halls K.S., Hammond S., Harley J.L., Hart E.A., RA Heath P.D., Heathcott R., Holmes S.J., Howden P.J., Howe K.L., Howell G.R., RA Huckle E., Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., RA Joy A.A., Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., RA Langford C., Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., RA Lloyd D.M., Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M., RA Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K., McMurray A., RA Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T., Novik K.L., RA Oliver K., Overton-Larty E.K., Parker A., Patel R., Pearce A.V., Peck A.I., RA Phillimore B.J.C.T., Phillips S., Plumb R.W., Porter K.M., Ramsey Y., RA Ranby S.A., Rice C.M., Ross M.T., Searle S.M., Sehra H.K., Sheridan E., RA Skuce C.D., Smith S., Smith M., Spraggon L., Squares S.L., Steward C.A., RA Sycamore N., Tamlyn-Hall G., Tester J., Theaker A.J., Thomas D.W., RA Thorpe A., Tracey A., Tromans A., Tubby B., Wall M., Wallis J.M., RA West A.P., White S.S., Whitehead S.L., Whittaker H., Wild A., Willey D.J., RA Wilmer T.E., Wood J.M., Wray P.W., Wyatt J.C., Young L., Younger R.M., RA Bentley D.R., Coulson A., Durbin R.M., Hubbard T., Sulston J.E., Dunham I., RA Rogers J., Beck S.; RT "The DNA sequence and analysis of human chromosome 6."; RL Nature 425:805-811(2003). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. RC TISSUE=Placenta; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP NUCLEOTIDE SEQUENCE [MRNA] OF 30-222, AND VARIANT LEU-71. RX PubMed=9480897; DOI=10.1042/bj3300827; RA Board P.G.; RT "Identification of cDNAs encoding two human alpha class glutathione RT transferases (GSTA3 and GSTA4) and the heterologous expression of RT GSTA4-4."; RL Biochem. J. 330:827-831(1998). RN [8] RP X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE, RP BIOPHYSICOCHEMICAL PROPERTIES, AND FUNCTION. RX PubMed=15595823; DOI=10.1021/bi048757g; RA Gu Y., Guo J., Pal A., Pan S.S., Zimniak P., Singh S.V., Ji X.; RT "Crystal structure of human glutathione S-transferase A3-3 and mechanistic RT implications for its high steroid isomerase activity."; RL Biochemistry 43:15673-15679(2004). RN [9] RP X-RAY CRYSTALLOGRAPHY (1.8 ANGSTROMS) IN COMPLEX WITH GLUTATHIONE AND RP DELTA5-ANDROSTENE-3-17-DIONE, FUNCTION, AND SUBUNIT. RX PubMed=20083122; DOI=10.1016/j.jmb.2010.01.023; RA Tars K., Olin B., Mannervik B.; RT "Structural basis for featuring of steroid isomerase activity in alpha RT class glutathione transferases."; RL J. Mol. Biol. 397:332-340(2010). CC -!- FUNCTION: Conjugation of reduced glutathione to a wide number of CC exogenous and endogenous hydrophobic electrophiles. Catalyzes CC isomerization reactions that contribute to the biosynthesis of steroid CC hormones. Efficiently catalyze obligatory double-bond isomerizations of CC delta(5)-androstene-3,17-dione and delta(5)-pregnene-3,20-dione, CC precursors to testosterone and progesterone, respectively. Has CC substantial activity toward aflatoxin B1-8,9-epoxide (By similarity). CC {ECO:0000250|UniProtKB:P30115, ECO:0000269|PubMed:11418619, CC ECO:0000269|PubMed:15595823, ECO:0000269|PubMed:20083122}. CC -!- CATALYTIC ACTIVITY: CC Reaction=glutathione + RX = a halide anion + an S-substituted CC glutathione + H(+); Xref=Rhea:RHEA:16437, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:16042, ChEBI:CHEBI:17792, ChEBI:CHEBI:57925, CC ChEBI:CHEBI:90779; EC=2.5.1.18; CC Evidence={ECO:0000305|PubMed:11418619}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:16438; CC Evidence={ECO:0000305|PubMed:11418619}; CC -!- CATALYTIC ACTIVITY: CC Reaction=androst-5-ene-3,17-dione = androst-4-ene-3,17-dione; CC Xref=Rhea:RHEA:43936, ChEBI:CHEBI:16422, ChEBI:CHEBI:83865; CC Evidence={ECO:0000269|PubMed:11418619}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43937; CC Evidence={ECO:0000305|PubMed:11418619}; CC -!- CATALYTIC ACTIVITY: CC Reaction=pregn-5-ene-3,20-dione = progesterone; Xref=Rhea:RHEA:43928, CC ChEBI:CHEBI:17026, ChEBI:CHEBI:63837; CC Evidence={ECO:0000269|PubMed:11418619}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:43929; CC Evidence={ECO:0000305|PubMed:11418619}; CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=23 uM for androst-5-ene-3,17-dione {ECO:0000269|PubMed:15595823}; CC KM=24 uM for androst-5-ene-3,17-dione (at pH 8.0 and 30 degrees CC Celsius) {ECO:0000269|PubMed:11418619}; CC KM=24 uM for androst-5-ene-3,17-dione (at pH 7.4 and 37 degrees CC Celsius) {ECO:0000269|PubMed:11418619}; CC KM=17 uM for pregn-5-ene-3,20-dione (at pH 8.0 and 30 degrees CC Celsius) {ECO:0000269|PubMed:11418619}; CC KM=17 uM for pregn-5-ene-3,20-dione (at pH 7.4 and 37 degrees CC Celsius) {ECO:0000269|PubMed:11418619}; CC Vmax=99 umol/min/mg enzyme for delta(5)-androstene-3,17-dione CC isomerization {ECO:0000269|PubMed:15595823}; CC Note=kcats are 102 sec(-1) and 27 sec(-1) for CC androst-5-ene-3,17-dione and pregn-5-ene-3,20-dione as substrates, CC respectively (at pH 8.0 and 30 degrees Celsius). CC {ECO:0000269|PubMed:11418619}; CC -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:15595823, CC ECO:0000269|PubMed:20083122}. CC -!- SUBCELLULAR LOCATION: Cytoplasm. CC -!- SIMILARITY: Belongs to the GST superfamily. Alpha family. CC {ECO:0000305}. CC -!- SEQUENCE CAUTION: CC Sequence=AAA74634.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC Sequence=AAD04712.1; Type=Erroneous initiation; Note=Extended N-terminus.; Evidence={ECO:0000305}; CC -!- WEB RESOURCE: Name=NIEHS-SNPs; CC URL="http://egp.gs.washington.edu/data/gsta3/"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; L13275; AAA74634.1; ALT_INIT; Genomic_DNA. DR EMBL; L13270; AAA74634.1; JOINED; Genomic_DNA. DR EMBL; L13271; AAA74634.1; JOINED; Genomic_DNA. DR EMBL; L13272; AAA74634.1; JOINED; Genomic_DNA. DR EMBL; L13273; AAA74634.1; JOINED; Genomic_DNA. DR EMBL; L13274; AAA74634.1; JOINED; Genomic_DNA. DR EMBL; AF508266; AAM33360.1; -; mRNA. DR EMBL; DQ993361; ABI75350.1; -; Genomic_DNA. DR EMBL; AL121969; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471081; EAX04391.1; -; Genomic_DNA. DR EMBL; BC020619; AAH20619.1; -; mRNA. DR EMBL; AF020919; AAD04712.1; ALT_INIT; mRNA. DR CCDS; CCDS4947.1; -. DR PIR; A49365; A49365. DR RefSeq; NP_000838.3; NM_000847.4. DR PDB; 1TDI; X-ray; 2.40 A; A/B=1-222. DR PDB; 2VCV; X-ray; 1.80 A; A/B/C/D/E/F/G/H/I/J/K/L/M/N/O/P=1-222. DR PDBsum; 1TDI; -. DR PDBsum; 2VCV; -. DR AlphaFoldDB; Q16772; -. DR SMR; Q16772; -. DR BioGRID; 109195; 4. DR IntAct; Q16772; 1. DR STRING; 9606.ENSP00000211122; -. DR ChEMBL; CHEMBL4866; -. DR DrugBank; DB04521; 4-S-Glutathionyl-5-pentyl-tetrahydro-furan-2-ol. DR DrugBank; DB00143; Glutathione. DR SwissLipids; SLP:000001612; -. DR iPTMnet; Q16772; -. DR PhosphoSitePlus; Q16772; -. DR BioMuta; GSTA3; -. DR DMDM; 21264437; -. DR jPOST; Q16772; -. DR MassIVE; Q16772; -. DR MaxQB; Q16772; -. DR PaxDb; 9606-ENSP00000211122; -. DR PeptideAtlas; Q16772; -. DR ProteomicsDB; 61058; -. DR Antibodypedia; 30950; 336 antibodies from 29 providers. DR DNASU; 2940; -. DR Ensembl; ENST00000211122.4; ENSP00000211122.3; ENSG00000174156.15. DR GeneID; 2940; -. DR KEGG; hsa:2940; -. DR MANE-Select; ENST00000211122.4; ENSP00000211122.3; NM_000847.5; NP_000838.3. DR UCSC; uc003pbb.4; human. DR AGR; HGNC:4628; -. DR CTD; 2940; -. DR DisGeNET; 2940; -. DR GeneCards; GSTA3; -. DR HGNC; HGNC:4628; GSTA3. DR HPA; ENSG00000174156; Group enriched (adrenal gland, fallopian tube, placenta, skin). DR MIM; 605449; gene. DR neXtProt; NX_Q16772; -. DR OpenTargets; ENSG00000174156; -. DR PharmGKB; PA29018; -. DR VEuPathDB; HostDB:ENSG00000174156; -. DR eggNOG; KOG1695; Eukaryota. DR GeneTree; ENSGT00940000164319; -. DR HOGENOM; CLU_039475_4_0_1; -. DR InParanoid; Q16772; -. DR OMA; FTEMIMN; -. DR OrthoDB; 3412208at2759; -. DR PhylomeDB; Q16772; -. DR TreeFam; TF105321; -. DR BRENDA; 2.5.1.18; 2681. DR BRENDA; 5.3.3.1; 2681. DR PathwayCommons; Q16772; -. DR Reactome; R-HSA-156590; Glutathione conjugation. DR Reactome; R-HSA-9818027; NFE2L2 regulating anti-oxidant/detoxification enzymes. DR SABIO-RK; Q16772; -. DR SignaLink; Q16772; -. DR BioGRID-ORCS; 2940; 10 hits in 1084 CRISPR screens. DR EvolutionaryTrace; Q16772; -. DR GeneWiki; GSTA3; -. DR GenomeRNAi; 2940; -. DR Pharos; Q16772; Tbio. DR PRO; PR:Q16772; -. DR Proteomes; UP000005640; Chromosome 6. DR RNAct; Q16772; Protein. DR Bgee; ENSG00000174156; Expressed in right uterine tube and 103 other cell types or tissues. DR ExpressionAtlas; Q16772; baseline and differential. DR GO; GO:0005829; C:cytosol; IDA:HPA. DR GO; GO:0070062; C:extracellular exosome; HDA:UniProtKB. DR GO; GO:0004364; F:glutathione transferase activity; ISS:UniProtKB. DR GO; GO:0006749; P:glutathione metabolic process; ISS:UniProtKB. DR GO; GO:0006629; P:lipid metabolic process; IEA:UniProtKB-KW. DR GO; GO:0006805; P:xenobiotic metabolic process; IBA:GO_Central. DR CDD; cd03208; GST_C_Alpha; 1. DR CDD; cd03077; GST_N_Alpha; 1. DR Gene3D; 1.20.1050.10; -; 1. DR Gene3D; 3.40.30.10; Glutaredoxin; 1. DR InterPro; IPR010987; Glutathione-S-Trfase_C-like. DR InterPro; IPR036282; Glutathione-S-Trfase_C_sf. DR InterPro; IPR040079; Glutathione_S-Trfase. DR InterPro; IPR004045; Glutathione_S-Trfase_N. DR InterPro; IPR003080; GST_alpha. DR InterPro; IPR004046; GST_C. DR InterPro; IPR036249; Thioredoxin-like_sf. DR PANTHER; PTHR11571; GLUTATHIONE S-TRANSFERASE; 1. DR PANTHER; PTHR11571:SF257; GLUTATHIONE S-TRANSFERASE A3; 1. DR Pfam; PF00043; GST_C; 1. DR Pfam; PF02798; GST_N; 1. DR PRINTS; PR01266; GSTRNSFRASEA. DR SFLD; SFLDG01205; AMPS.1; 1. DR SFLD; SFLDS00019; Glutathione_Transferase_(cytos; 1. DR SUPFAM; SSF47616; GST C-terminal domain-like; 1. DR SUPFAM; SSF52833; Thioredoxin-like; 1. DR PROSITE; PS50405; GST_CTER; 1. DR PROSITE; PS50404; GST_NTER; 1. DR Genevisible; Q16772; HS. PE 1: Evidence at protein level; KW 3D-structure; Acetylation; Cytoplasm; Lipid metabolism; Reference proteome; KW Transferase. FT INIT_MET 1 FT /note="Removed" FT /evidence="ECO:0000250|UniProtKB:P30115" FT CHAIN 2..222 FT /note="Glutathione S-transferase A3" FT /id="PRO_0000185785" FT DOMAIN 3..83 FT /note="GST N-terminal" FT DOMAIN 85..207 FT /note="GST C-terminal" FT BINDING 9 FT /ligand="glutathione" FT /ligand_id="ChEBI:CHEBI:57925" FT /evidence="ECO:0000269|PubMed:15595823, FT ECO:0000269|PubMed:20083122" FT BINDING 45 FT /ligand="glutathione" FT /ligand_id="ChEBI:CHEBI:57925" FT /evidence="ECO:0000269|PubMed:15595823, FT ECO:0000269|PubMed:20083122" FT BINDING 54..55 FT /ligand="glutathione" FT /ligand_id="ChEBI:CHEBI:57925" FT /evidence="ECO:0000269|PubMed:15595823, FT ECO:0000269|PubMed:20083122" FT BINDING 67..68 FT /ligand="glutathione" FT /ligand_id="ChEBI:CHEBI:57925" FT /evidence="ECO:0000269|PubMed:15595823, FT ECO:0000269|PubMed:20083122" FT MOD_RES 2 FT /note="N-acetylalanine" FT /evidence="ECO:0000250|UniProtKB:P30115" FT MOD_RES 4 FT /note="N6-succinyllysine" FT /evidence="ECO:0000250|UniProtKB:P30115" FT VARIANT 36 FT /note="G -> E (in dbSNP:rs45504096)" FT /evidence="ECO:0000269|Ref.3" FT /id="VAR_062276" FT VARIANT 71 FT /note="I -> L (in dbSNP:rs1052661)" FT /evidence="ECO:0000269|PubMed:9480897, ECO:0000269|Ref.3" FT /id="VAR_049484" FT VARIANT 73 FT /note="N -> D (in dbSNP:rs41273858)" FT /evidence="ECO:0000269|Ref.3" FT /id="VAR_049485" FT VARIANT 113 FT /note="R -> Q (in dbSNP:rs45602042)" FT /evidence="ECO:0000269|Ref.3" FT /id="VAR_062277" FT VARIANT 208 FT /note="A -> T (in dbSNP:rs45620832)" FT /evidence="ECO:0000269|Ref.3" FT /id="VAR_062278" FT CONFLICT 63 FT /note="M -> I (in Ref. 6; AAH20619)" FT /evidence="ECO:0000305" FT CONFLICT 113..114 FT /note="RP -> PA (in Ref. 1; AAA74634)" FT /evidence="ECO:0000305" FT CONFLICT 128 FT /note="T -> I (in Ref. 1; AAA74634)" FT /evidence="ECO:0000305" FT STRAND 6..9 FT /evidence="ECO:0007829|PDB:2VCV" FT TURN 14..16 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 17..25 FT /evidence="ECO:0007829|PDB:2VCV" FT STRAND 31..34 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 38..46 FT /evidence="ECO:0007829|PDB:2VCV" FT STRAND 57..60 FT /evidence="ECO:0007829|PDB:2VCV" FT STRAND 63..67 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 68..78 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 86..108 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 109..111 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 114..130 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 132..143 FT /evidence="ECO:0007829|PDB:2VCV" FT STRAND 146..149 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 155..170 FT /evidence="ECO:0007829|PDB:2VCV" FT TURN 172..177 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 179..190 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 192..197 FT /evidence="ECO:0007829|PDB:2VCV" FT HELIX 210..220 FT /evidence="ECO:0007829|PDB:2VCV" SQ SEQUENCE 222 AA; 25302 MW; 904AA17519B5343C CRC64; MAGKPKLHYF NGRGRMEPIR WLLAAAGVEF EEKFIGSAED LGKLRNDGSL MFQQVPMVEI DGMKLVQTRA ILNYIASKYN LYGKDIKERA LIDMYTEGMA DLNEMILLLP LCRPEEKDAK IALIKEKTKS RYFPAFEKVL QSHGQDYLVG NKLSRADISL VELLYYVEEL DSSLISNFPL LKALKTRISN LPTVKKFLQP GSPRKPPADA KALEEARKIF RF //